Simplex Trading
ADIL

Simplex Trading’s Adial Pharmaceuticals ADIL Stock Holding History

Simplex Trading’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed -$1K – 9069
2022
Q3 		$1K Sell
7
-17
-71% -$7.67K ﹤0.01% 9471
2022
Q2 		$20K Sell
24
-31
-56% -$28.1K ﹤0.01% 7588
2022
Q1 		$69K Buy
55
+27
+96% +$37K ﹤0.01% 6668
2021
Q4 		$46K Buy
+28
New +$55.1K ﹤0.01% 7359

Other funds holding ADIL

MCM
Manchester Capital Management Manchester, Vermont $694M AUM 22.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Simplex Trading's ADIL Position: Q2 2023 in Review

Simplex Trading sold out of Adial Pharmaceuticals (ADIL) in Q2 2023, closing a stake of 4 shares — an estimated $723 sold.

Simplex Trading first reported a position in ADIL in Q2 2022 and held it in 3 quarters. The position peaked at $10K in Q2 2022. 19 funds tracked by Wall St. Rank hold ADIL as of Q2 2023.

  • Simplex Trading reported no remaining Adial Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 4 Adial Pharmaceuticals shares in Q2 2023, an estimated $723.
  • Simplex Trading first reported a position in Adial Pharmaceuticals in Q2 2022 and held it in 3 quarters.
  • Simplex Trading's Adial Pharmaceuticals position peaked at $10K in Q2 2022.
  • 19 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.